Lates News

The US pharmaceutical sector fell, failing to continue this week's gains. As of press time, Novo Nordisk (NVO.US) fell more than 3%, Moderna (MRNA.US) fell more than 2.4%, Eli Lilly (LLY.US) fell more than 1%, and Pfizer (PFE.US) fell nearly 1%. In terms of news, it is reported that the FDA may accelerate drug reviews to lower drug prices in the United States.